- Home
- GECC vs BYSI Comparison
GECC vs BYSI Comparison
Compare GECC & BYSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GECC
- BYSI
- Stock Information
- Founded
- GECC 2016
- BYSI 2010
- Country
- GECC United States
- BYSI United States
- Employees
- GECC N/A
- BYSI N/A
- Industry
- GECC Finance: Consumer Services
- BYSI Biotechnology: Pharmaceutical Preparations
- Sector
- GECC Finance
- BYSI Health Care
- Exchange
- GECC Nasdaq
- BYSI Nasdaq
- Market Cap
- GECC 105.4M
- BYSI 99.5M
- IPO Year
- GECC N/A
- BYSI 2017
- Fundamental
- Price
- GECC $10.06
- BYSI $2.39
- Analyst Decision
- GECC
- BYSI
- Analyst Count
- GECC 0
- BYSI 0
- Target Price
- GECC N/A
- BYSI N/A
- AVG Volume (30 Days)
- GECC 14.4K
- BYSI 24.9K
- Earning Date
- GECC 10-31-2024
- BYSI 01-01-0001
- Dividend Yield
- GECC 13.92%
- BYSI N/A
- EPS Growth
- GECC 25.36
- BYSI N/A
- EPS
- GECC 1.22
- BYSI N/A
- Revenue
- GECC $36,895,000.00
- BYSI $1,876,000.00
- Revenue This Year
- GECC $15.88
- BYSI N/A
- Revenue Next Year
- GECC $8.88
- BYSI N/A
- P/E Ratio
- GECC $8.25
- BYSI N/A
- Revenue Growth
- GECC 20.00
- BYSI 21.03
- 52 Week Low
- GECC $8.38
- BYSI $0.78
- 52 Week High
- GECC $11.82
- BYSI $4.00
- Technical
- Relative Strength Index (RSI)
- GECC 47.29
- BYSI 55.53
- Support Level
- GECC $9.92
- BYSI $2.27
- Resistance Level
- GECC $10.14
- BYSI $2.53
- Average True Range (ATR)
- GECC 0.16
- BYSI 0.19
- MACD
- GECC 0.02
- BYSI -0.00
- Stochastic Oscillator
- GECC 38.78
- BYSI 53.33
About GECC Great Elm Capital Corp.
Great Elm Capital Corp is an externally managed, non-diversified closed-end management investment company. The company seeks to generate current income and capital appreciation through debt and equity investments, including investments in specialty finance businesses. It invests in senior secured and senior unsecured debt instruments, as well as in junior loans and mezzanine debt of middle-market companies and small businesses. The company generates revenue from interest on the debt investments that it holds.
About BYSI BeyondSpring Inc.
BeyondSpring Inc is engaged in clinical-stage biopharmaceutical activities focused on the development of cancer therapies. It is also focused on including immuno-oncology agents. It has two reportable segments Plinabulin pipeline and the TPD platform.